Title | Reassessment of biochemically determined Hunter syndrome carrier status by DNA testing. |
Publication Type | Journal Article |
Year of Publication | 1998 |
Authors | Timms, KM, Edwards, FJ, Belmont, JW, Yates, JR, Gibbs, RA |
Journal | J Med Genet |
Volume | 35 |
Issue | 8 |
Pagination | 646-9 |
Date Published | 1998 Aug |
ISSN | 0022-2593 |
Keywords | DNA, Female, Heterozygote, Humans, Iduronate Sulfatase, Male, Mucopolysaccharidosis II, Pedigree |
Abstract | Deficiency of iduronate-2-sulphatase (IDS) results in the X linked recessive lysosomal storage disorder Hunter syndrome. Determination of carrier status in families affected by this disorder has been performed using a variety of enzymatic tests. None of these tests has proved to be 100% effective at identifying carriers. The aim of this study was to perform carrier testing in a family affected by the disorder, where testing was complicated by the fact that no surviving affected subjects were available for study. Direct dye primer sequencing of PCR products was used to identify mixed bases in an obligate carrier. Two mixed bases were observed within exon VIII. The first base change (T-->A) at nucleotide position 1150 results in a missense mutation (H342Q), while the second base change (G-->T) at nucleotide position 1151 results in a nonsense mutation (G343X). Four additional female family members were screened for the same mutation. Using this approach it is possible to provide unambiguous information about a subject's carrier status and, unlike biochemical testing, this approach will be equally effective when applied to families with the mild form of this disorder. |
DOI | 10.1136/jmg.35.8.646 |
Alternate Journal | J Med Genet |
PubMed ID | 9719370 |
PubMed Central ID | PMC1051389 |
Grant List | P30 HG00210 / HG / NHGRI NIH HHS / United States R01 HG00823 / HG / NHGRI NIH HHS / United States |
Reassessment of biochemically determined Hunter syndrome carrier status by DNA testing.
Similar Publications
DNA Methylation-Derived Immune Cell Proportions and Cancer Risk in Black Participants. Cancer Res Commun. 2024;4(10):2714-2723. | .
StratoMod: predicting sequencing and variant calling errors with interpretable machine learning. Commun Biol. 2024;7(1):1316. | .
Identification of allele-specific KIV-2 repeats and impact on Lp(a) measurements for cardiovascular disease risk. BMC Med Genomics. 2024;17(1):255. | .